Gerresheimer AG (GXI.DE)
EUR 60.55
(1.94%)
EUR 60.55
(1.94%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.42 Billion EUR | 2.23% |
| 2022 | 3.35 Billion EUR | 16.57% |
| 2021 | 2.87 Billion EUR | 9.97% |
| 2020 | 2.61 Billion EUR | -0.93% |
| 2019 | 2.64 Billion EUR | -3.28% |
| 2018 | 2.73 Billion EUR | 11.74% |
| 2017 | 2.44 Billion EUR | 2.94% |
| 2016 | 2.37 Billion EUR | -1.89% |
| 2015 | 2.41 Billion EUR | 46.14% |
| 2014 | 1.65 Billion EUR | 2.49% |
| 2013 | 1.61 Billion EUR | 3.72% |
| 2012 | 1.55 Billion EUR | 2.82% |
| 2011 | 1.51 Billion EUR | 11.58% |
| 2010 | 1.35 Billion EUR | 1.28% |
| 2009 | 1.34 Billion EUR | -12.85% |
| 2008 | 1.53 Billion EUR | 6.68% |
| 2007 | 1.44 Billion EUR | 7024.15% |
| 2006 | -20.82 Million EUR | -550.39% |
| 2005 | 4.62 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.46 Billion EUR | 1.17% |
| 2024 Q2 | 3.54 Billion EUR | 2.16% |
| 2024 Q3 | 3.56 Billion EUR | 0.54% |
| 2023 Q3 | 3.35 Billion EUR | 1.32% |
| 2023 FY | 3.42 Billion EUR | 2.23% |
| 2023 Q1 | 3.26 Billion EUR | -2.71% |
| 2023 Q2 | 3.31 Billion EUR | 1.52% |
| 2023 Q4 | 3.42 Billion EUR | 2.17% |
| 2022 Q3 | 3.53 Billion EUR | 11.09% |
| 2022 Q4 | 3.35 Billion EUR | -5.21% |
| 2022 FY | 3.35 Billion EUR | 16.57% |
| 2022 Q1 | 2.96 Billion EUR | 2.88% |
| 2022 Q2 | 3.18 Billion EUR | 7.6% |
| 2021 Q1 | 2.6 Billion EUR | -0.47% |
| 2021 Q3 | 2.73 Billion EUR | 3.07% |
| 2021 FY | 2.87 Billion EUR | 9.97% |
| 2021 Q4 | 2.87 Billion EUR | 5.05% |
| 2021 Q2 | 2.65 Billion EUR | 2.05% |
| 2020 FY | 2.61 Billion EUR | -0.93% |
| 2020 Q1 | 2.65 Billion EUR | 0.34% |
| 2020 Q4 | 2.61 Billion EUR | 1.33% |
| 2020 Q3 | 2.58 Billion EUR | -2.02% |
| 2020 Q2 | 2.63 Billion EUR | -0.56% |
| 2019 Q3 | 2.74 Billion EUR | 0.22% |
| 2019 Q1 | 2.68 Billion EUR | -1.53% |
| 2019 FY | 2.64 Billion EUR | -3.28% |
| 2019 Q2 | 2.74 Billion EUR | 1.9% |
| 2019 Q4 | 2.64 Billion EUR | -3.83% |
| 2018 Q2 | 2.24 Billion EUR | -6.03% |
| 2018 FY | 2.73 Billion EUR | 11.74% |
| 2018 Q4 | 2.73 Billion EUR | 3.01% |
| 2018 Q3 | 2.65 Billion EUR | 18.11% |
| 2018 Q1 | 2.38 Billion EUR | -2.28% |
| 2017 Q1 | 2.37 Billion EUR | -0.02% |
| 2017 FY | 2.44 Billion EUR | 2.94% |
| 2017 Q4 | 2.44 Billion EUR | 8.34% |
| 2017 Q3 | 2.25 Billion EUR | -1.46% |
| 2017 Q2 | 2.28 Billion EUR | -3.56% |
| 2016 FY | 2.37 Billion EUR | -1.89% |
| 2016 Q3 | 2.39 Billion EUR | 1.67% |
| 2016 Q2 | 2.35 Billion EUR | 0.02% |
| 2016 Q1 | 2.35 Billion EUR | -2.53% |
| 2016 Q4 | 2.37 Billion EUR | -1.03% |
| 2015 Q3 | 1.66 Billion EUR | -1.88% |
| 2015 Q4 | 2.41 Billion EUR | 45.01% |
| 2015 Q2 | 1.7 Billion EUR | 0.3% |
| 2015 Q1 | 1.69 Billion EUR | 2.4% |
| 2015 FY | 2.41 Billion EUR | 46.14% |
| 2014 Q4 | 1.65 Billion EUR | 1.6% |
| 2014 Q3 | 1.62 Billion EUR | -0.17% |
| 2014 Q2 | 1.63 Billion EUR | 1.84% |
| 2014 Q1 | 1.6 Billion EUR | -0.79% |
| 2014 FY | 1.65 Billion EUR | 2.49% |
| 2013 Q4 | 1.61 Billion EUR | 0.25% |
| 2013 Q3 | 1.61 Billion EUR | -3.19% |
| 2013 Q2 | 1.66 Billion EUR | 3.53% |
| 2013 Q1 | 1.6 Billion EUR | 3.23% |
| 2013 FY | 1.61 Billion EUR | 3.72% |
| 2012 Q2 | 1.53 Billion EUR | 1.21% |
| 2012 FY | 1.55 Billion EUR | 2.82% |
| 2012 Q4 | 1.55 Billion EUR | 1.64% |
| 2012 Q3 | 1.53 Billion EUR | 0.05% |
| 2012 Q1 | 1.51 Billion EUR | -0.1% |
| 2011 FY | 1.51 Billion EUR | 11.58% |
| 2011 Q3 | 1.46 Billion EUR | -0.17% |
| 2011 Q2 | 1.47 Billion EUR | 10.27% |
| 2011 Q4 | 1.51 Billion EUR | 3.11% |
| 2011 Q1 | 1.33 Billion EUR | -1.69% |
| 2010 FY | 1.35 Billion EUR | 1.28% |
| 2010 Q4 | 1.35 Billion EUR | 0.43% |
| 2010 Q3 | 1.35 Billion EUR | -1.38% |
| 2010 Q2 | 1.37 Billion EUR | 2.06% |
| 2010 Q1 | 1.34 Billion EUR | 0.21% |
| 2009 FY | 1.34 Billion EUR | -12.85% |
| 2009 Q4 | 1.34 Billion EUR | 0.0% |
| 2008 FY | 1.53 Billion EUR | 6.68% |
| 2007 FY | 1.44 Billion EUR | 7024.15% |
| 2006 FY | -20.82 Million EUR | -550.39% |
| 2005 FY | 4.62 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 1.23 Billion EUR | -178.378% |
| Carl Zeiss Meditec AG | 3.03 Billion EUR | -13.064% |
| Fielmann Aktiengesellschaft | 2.13 Billion EUR | -60.56% |
| Sartorius Aktiengesellschaft | 9.75 Billion EUR | 64.848% |
| Sartorius Aktiengesellschaft | 9.75 Billion EUR | 64.848% |